- Internal restructuring
- Location of affected unit(s)
- Lacassagne (Lyon)
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
- Announcement Date
- 11 July 2003
- Employment effect (start)
- 1 July 2003
- Foreseen end date
- 1 June 2006
Merck Santé, subsidiary of Merck KGaA, announced a restructuring programme for its production and research and development (R&D) units in France. 320 jobs are affected at the Lacassagne (Lyon) unit. Half of the R&D department will be closed by the end of 2004 and half of the production department will be closed by mid-2006. Production will be transfered to the unit of Semoy (Loiret) and in Spain.
The idea of the restructuring plan comes from two studies: 'Ipso' and 'Everest' from Boston Consulting Group and Accenture.
Eurofound (2003), Merck santé, Internal restructuring in France, factsheet number 59300, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/59300.